Brian Huber

Brian Huber is vice-president of Therapeutic Areas, Drug Development, and Consulting at ICON.

Articles

Difficulties in Expanding CAR-T Cell Therapy into Solid Tumors

There are various challenges associated with the development of CAR-T therapies for solid tumor cancers.

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.